1910
1910 is an AI-native biotech building an AI infrastructure for therapeutics discovery by integrating multimodal data, frontier AI models, and lab automation. The AI Research Scientist II role contributes as an individual contributor within the company's research organization to advance AI-driven drug discovery efforts and support the company’s mission to deliver diverse drug modalities.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2018
1910 is an AI-native biotech company building multimodal, modality-agnostic AI infrastructure for pharmaceutical R&D. Its ITO™ platform integrates wet‑lab, computational, and proxy data to power predictive models and end‑to‑end workflows that help companies discover and reliably "drug the undruggable." 1910’s technology is designed to accelerate target selection, molecule design, and experimental decision‑making, reducing time and cost in the drug discovery pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 1910.
1910 didn’t post a salary, so this is our estimate from similar listings.
Bucoda incorporates on July 5, 1910.
Sep 2, 2025